M&A: Centene to Acquire AI Healthcare Analytics Platform Apixio

What You Should Know:

Centene Corporation, today
revealed it has actually signed a conclusive arrangement to obtain
Apixio Inc., a AI health care analytics business providing Artificial
Intelligence (AI) technology services. The transaction undergoes
regulatory approvals and is expected to nearby completion of 2020.

Better Data. Better Healthcare

— Apixio will remain an operationally independent entity
as part of Centenes Health Care Enterprises group to continue bringing worth
to its clients and the market.

Apixio helps organizations use their information for understanding about patient health. Apixios device knowing and deep knowing algorithms examine disorganized information embedded in electronic health records, scanned notes, facsimiles, and handwritten notes to produce top quality forecasts for measurement, discovery, and care.

— Centene Corporation gets AI health care analytics platform
Apixio to extra data and AI ability to innovation portfolio.

The Apixio Platform

Acquisition Complements Centenes Existing Data Analytics
Products

The Apixio Platform can mine textual information and combine its generated insights with offered structured data to craft computable individual health profiles or phenotypes. We evaluate our put together phenotypes in real-time utilizing a versatile guidelines engine. This automates the execution of clinical guidelines, quality and threat steps, payment or reimbursement policies, and other functional and administrative guidelines, to support vital healthcare activities.

As part of the acquisition, Apixio will stay an
operationally independent entity as part of Centenes Health Care Enterprises
Group to continue bringing value to its clients and the industry, while
realizing the advantages of enhanced scale with Centene. Financial information of the
acquisition were not disclosed.

< " Centene is dedicated to speeding up development, modernization and digitization across the business and solidify its position as a technology business concentrated on healthcare. Apixios abilities are closely aligned with our plans to digitize the administration of healthcare and to utilize detailed data to help enhance the lives of our members," stated Michael F. Neidorff, Chairman, President and Chief Executive Officer for Centene. "Apixios technology will match existing information analytics products consisting of Interpreta, creating a separated platform to expand support for value-based health care payment and shipment with actionable intelligence."